Ronghua Tao, Ph.D.^1*, Zuzana Berkova^2*, Shu Wang, M.D.^2*, Suizhao Wang, M.D., Ph.D.^2*, Jillian Wise, BS^1* and Hoyoung Maeng, M.D.^1*

¹Lymphoma/Myeloma, M.D. Anderson Cancer Center, Houston, TX
²Lymphoma/Myeloma, M. D. Anderson Cancer Center, Houston, TX

Volker Diehl¹, Heinz Haverkamp^2*, Rolf Peter Mueller^3*, Hans Theodor Eich^4*, Hans Konrad Mueller-Hermelink^5*, Thomas Cerny^6*, Jana Markova^7*, Anthony Ho⁸, Lothar Kanz⁹, Richard Greil^10*, Wolfgang Hiddemann^11* and Andreas Engert²

¹University of Cologne, Cologne/Germany, Germany
²First department of Internal Medicine / German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany
³Department of Radiotherapy, University of Cologne, Cologne, Germany
⁴Department of Radiotherapy, University of Cologne, Cologne/Germany, Germany
⁵Department of Pathology, University of Wuerzburg, Wuerzburg, Germany
⁶Department of Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland
⁷Clinic Hematologia, Fakultne Nemocnice Kralovska Vinohrady, Prague, Czech Republic
⁸Department of Hematology and Oncology, University of Heidelberg, Heidelberg, Germany
⁹Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany
¹⁰Third Department of Internal Medicine, University of Salzburg, Salzburg, Austria
¹¹Third Department of Internal Medicine, University of Munic, Munic, Germany

Jorge Romaguera¹, Bertrand Coiffier², Michael Crump³, Raoul Herbrecht⁴, Gregor Verhoef⁵, Orysia Hanushevsky^6*, Andrew Strahs^6*, Becker Hewes⁶, Anna Berkenblit^6* and Georg Hess^7*

¹MD Anderson Cancer Center, Houston, TX
²Centre Hospitalier Lyon-Sud, Pierre-Benite, France
³Princess Margaret Hospital, Toronto, ON, Canada
⁴Hopital de Hautepierre, Strasbourg, France
⁵University Hospital, Leuven, Belgium
⁶Wyeth Research, Cambridge, MA
⁷Johannes Gutenberg-Universität, Mainz, Germany

Craig B. Reeder, MD¹, T.E. Witzig^2*, Julie M. Vose^3*, Pier Luigi Zinzani, MD^4*, Rena Buckstein, MD, FRCPC⁵, Corinne Haioun⁶, Reda Bouabdallah, MD⁷, Jonathan Polikoff, MD^8*, Pingshan Guo^9*, Annette Ervin-Haynes⁹, Dennis Pietronigro^9*, Jerome B. Zeldis, MD⁹ and Myron S. Czuczman, MD¹⁰

¹Hematology, Mayo Clinic Arizona, Scottsdale, AZ
²Health Sciences Research, Mayo Clinic, Rochester, MN
³Genetics, Cell Biology and Anatomy, University Of Nebraska Medical Center, Omaha, NE
⁴Department of Hematology/Oncology, University of Bologna, Bologna, Italy
⁵Dept. of Hematology/Oncology, Sunnybrook Odette Cancer Center, Toronto, ON, Canada
⁶Service d'Hématologie Clinique, Hôpital Henri Mondor, Créteil, France
⁷Institut Paoli-Calmettes, Marseille, France
⁸Kaiser Permanente Medical Group, San Diego, CA
⁹Celgene Corporation, Summit, NJ
¹⁰Roswell Park Cancer Institute, Buffalo, NY

Delphine Rolland^1*, Vincent Ribrag^2*, Corinne Haioun^3*, Herve Ghesquieres, MD^4*, Fabrice Jardin^5*, Reda Bouabdallah^6*, Patricia Franchi^7*, Josette Briere^8*, Eric De Kerviler^9*, Catherine Chassagne-Clement^10*, Mitch Raponi, PhD¹¹, Remi Houlgatte^12*, Jean-Philippe Jais^13* and Catherine Thieblemont¹⁴

¹INSERM U836 Equipe 7 - Faculte de Medecine, Universite J. Fourier, Grenoble, France
²Medecine, Institut Gustave Roussy, Villejuif, France
³Hematology, Henri Mondor Hospital, Creteil, France
⁴Hematology, Centre Léon Berard, Lyon, France
⁵Hematology, INSERM U918, Centre Henri Becquerel, Rouen, France
⁶Hematology, Cancer Centre Institut Paoli-Calmettes, Université de la Méditerranée, Marseille, France
⁷Hemato-oncologie, Hôpital Saint-Louis APHP, Paris, France
⁸Anatomo-pathologie, Hôpital Saint-Louis APHP - INSERM U728 - IUH, Paris, France
⁹Radiologie, Hopital Saint-Louis APHP, Paris, France
¹⁰Anatomie pathologique, Centre Léon Bérard, Lyon, France
¹¹Veridex, LLC, San Diego, CA
¹²INSERM U533 - Institut du thorax - Faculté de Médecine, Université de Nantes, Nantes, France
¹³Biostatistics, Hôpital Necker, EA 4067 université Paris-Descartes, Paris, France
¹⁴Hemato-Oncology, Hopital Saint-Louis, APHP - INSERM U 728 - Institut Universitaire d'Hematologie, Paris, France

Michael Craig^1*, Sandip Shah^2*, Martin Tallman^3*, Poonam Patil^4*, Jose Easow^5*, Jill Buck^6*, Sachin Shah^6*, Jonathan Lewis⁶ and Izidore S. Lossos⁷

¹West Virginia University Hospitals, Morgantown, WV
²Vendanta Institute of Medical Sciences, Ahmedabad, India
³Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
⁴Manipal Comprehensive Cancer Centre, Bangalore, India
⁵Apollo Hospital, Chennai, India
⁶ZIOPHARM Oncology, Inc., Boston, MA
⁷Sylvester Comprehensive Cancer Center, Miami, FL

John Gerecitano¹, O. O'Connor², H. Van Deventer^3*, J. Hainsworth⁴, J. Leonard⁵, A. Goy⁶, B. Afanasyev^7*, M. Chen^8*, K. Saikali^8*, M. G Conlan^8*, R Escandon^8* and A Wolff^8*

¹Memorial Sloan-Kettering Cancer Ctr., New York, NY
²Columbia Univ. Med. Ctr., New York, NY
³Univ. North Carolina, Chapel Hill, NC
⁴Sarah Cannon Cancer Ctr., Nashville, TN
⁵Cornell Med. College, New York, NY
⁶Hackensack Univ. Med. Ctr., Hackensack, NJ
⁷St. Petersburg State Med. Univ., St. Petersburg, Russia
⁸Cytokinetics, Inc., S. San Francisco, CA

Mark Kirschbaum, MD¹, Leslie Popplewell², Auayporn P. Nademanee³, Vinod Pullarkat⁴, Maria Delioukina^2*, Jasmine M. Zain^5*, Deron Matsuoka^3*, Bernadette Pulone^3*, Paul Frankel^3*, Igor Espinoza-Delgado, MD^6*, Stephen J. Forman^7*, David Gandara^8* and Edward Newman^3*

¹Division of Hematology, City of Hope National Medical Center, Duarte, CA
²City of Hope, Duarte, CA
³City of Hope National Medical Center, Duarte, CA
⁴Division of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
⁵Division of Medical Oncology, Columbia University College of Physicians and Surgeons, New York, NY
⁶Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD
⁷Hematology/HCT, City of Hope, Duarte, CA
⁸University of California-Davis, Sacramento, CA

Kensei Tobinai, MD, PhD¹, Michinori Ogura, MD, PhD², Kiyohiko Hatake, MD, PhD³, Yukio Kobayashi, MD, PhD^1*, Takashi Watanabe, MD, PhD^1*, Toshiki Uchida, MD, PhD^2*, Masanobu Kasai, MD^2*, Masahiro Yokoyama, MD^3*, Yasuhito Terui, MD, PhD³, Chiho Ono^4*, Masanao Akiyama^4* and Junko Ohata, MD, PhD^4*

¹Hematology and Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan
²Hematology & Oncology, Nagoya Daini Red Cross Hospital, Nagoya, Japan
³Oncology and Hematology, Cancer Institute Hospital, Tokyo, Japan
⁴Medical Research, Wyeth Research, Tokyo, Japan

Christophe Ferme, MD^1*, Maria Victoria Mateos, MD, PhD^2*, Sergio Szyldergemajn, MD^3*, Emanuele Zucca, MD^4*, Jose Espinoza, MD^3*, Javier Briones, MD^5*, Franck Morschhauser, MD^6*, Christian Gisselbrecht, MD^7* and Vincent Ribrag, MD¹

¹Dpt. of Medicine, Institut Gustave Roussy, Villejuif, France
²Dpt of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
³Clinical Oncology, PharmaMar, Colmenar Viejo (Madrid), Spain
⁴Laboratory of Experimental Oncology and Lymphoma Unit, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland
⁵Dpt of Hematology, Hospital Sant Pau, Barcelona, Spain
⁶Hematology, Centre Hospitalier Universitaire, Lille, France
⁷Institut Hematologie, Hopital Saint Louis, Paris, France

Richard Piekarz, MD, PhD^1*, John Wright, MD, PhD^2*, Robin Frye, RN^1*, Steven L. Allen, MD³, Michael Craig, MD^4*, Larisa Geskin, MD, FAAD^5*, Laura Hutchins, MD⁶, David Joske, MBBS, FRCPA, FRACP⁷, Mark Kirschbaum, MD⁸, John P Leonard, MD^9*, Miles Prince, MD¹⁰, Craig B. Reeder, MD¹¹, Elaine Jaffe, MD^1* and Susan Bates, MD^1*

¹National Cancer Institute, Bethesda, MD
²IDB CTEP NCI, Rockville, MD
³Medicine, North Shore University Hospital - LIJ, Lake Success, NY
⁴Mary Babb Randolph Cancer Center, Morgantown, WV
⁵Dermatology, University of Pittsburgh, Pittsburgh
⁶Univ. of AR for Med. Sciences, Little Rock, AR
⁷Haematology Care Center, Sir Charles Gairdner Hospital, Perth, WEA, Australia
⁸Division of Hematology, City of Hope National Medical Center, Duarte, CA
⁹Weill Medical College of Cornell, New York, NY
¹⁰Peter MacCallum Cancer Institute, East Melbourne, Australia
¹¹Hematology, Mayo Clinic Arizona, Scottsdale, AZ

Susan Bates, MD^1*, Richard Piekarz, MD, PhD^1*, John Wright, MD, PhD^2*, Robin Frye, RN^1*, William Douglas Figg Sr., PharmD^1*, Steven L. Allen, MD³, Michael Craig, MD^4*, Larisa Geskin, MD, FAAD^5*, Laura Hutchins, MD^6*, David Joske, MBBS, FRCPA, FRAPC^7*, Mark Kirschbaum, MD⁸, John P. Leonard, MD⁹, Miles Prince, MD¹⁰, Craig B. Reeder, MD¹¹, Maryalice Stetler-Stevenson, MD, PhD^1*, Alex Ling, MD^1* and Jean Nichols, PhD^12*

¹National Cancer Institute, Bethesda, MD
²IDB CTEP NCI, Rockville, MD
³Medicine, North Shore University Hospital - LIJ, Lake Success, NY
⁴West Virginia University Hospitals, Morgantown, WV
⁵Dermatology, University of Pittsburgh, Pittsburgh
⁶Arkansas Cancer Research Center, University of Arkansas for Medical Sciences, Little Rock, AR
⁷Sir Charles Gairdner Hospital, Nedlands, Australia
⁸Division of Hematology, City of Hope National Medical Center, Duarte, CA
⁹Division of Hem./Onc., Weill Cornell Medical College, New York, NY
¹⁰Peter MacCallum Cancer Institute, East Melbourne, Australia
¹¹Mayo Clinic, Scottsdale, AZ
¹²Gloucester Pharmaceuticals, Cambridge, MA

Steven M. Horwitz, MD¹, Madeleine Duvic, MD², Youn Kim, MD³, Jasmine M. Zain, MD⁴, Mary Jo Lechowicz, MD⁵, Patricia Myskowski, MD^1*, Hanna Weissbrot^1*, Danielle Wright^4*, Lacey Chance^6*, Tony Koutsoukos^6*, Pablo Cagnoni, MD^6*, Michael Saunders, MD^6* and Owen A. O'Connor, MD, PhD^4*

¹Memorial Sloan-Kettering Cancer Center, New York, NY
²M.D. Anderson Cancer Center, The University of Texas, Houston, TX
³Stanford, Stanford, CA
⁴CUMC, New York, NY
⁵Emory University, Atlanta, GA
⁶Allos Therapeutics, Inc., Westminster, CO

Steven M. Horwitz, MD¹, Julie M. Vose, MD², Ranjana Advani, MD³, Kamalesh Sankhala, MD^4*, Swaminathan Padmanabhan, M.D.^5*, Paul A. Hamlin Jr., MD¹, Andy Chen, MD, PhD⁶, Shannon Wilroy^7*, Jasmine M. Zain, MD⁸, Danielle Wright^8*, Hanna Weissbrot^1*, Maribeth Hohenstein^2*, Pablo J Cagnoni, MD^7*, Michael E Saunders, MD^7* and Owen A. O'Connor, MD, PhD^8*

¹Memorial Sloan-Kettering Cancer Center, New York, NY
²Univ. of NE Med. Ctr., Omaha, NE
³Stanford University, Stanford, CA
⁴University of Texas Health Science Center at San Antonio, San Antonio, TX
⁵Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX
⁶Stanford Cancer Center, Palo Alto, CA
⁷Allos Therapeutics, Inc., Westminster, CO
⁸CUMC, New York, NY

Thomas S. Lin, MD, PhD, Beth Fischer, BSN, RN^*, Kristie A. Blum, MD, Pierluigi Porcu, MD^*, Eric H. Kraut, MD, Robert A. Baiocchi, MD, PhD, Mollie E. Moran, MSN, CNP^*, Sarah Mitchell^*, Michael R. Grever, MD and John C. Byrd, MD

Division of Hematology and Oncology, The Ohio State University, Columbus, OH

Nicholas Di Bella, MD¹, Raymond Taetle, MD^2*, Kathryn S. Kolibaba, MD³, Thomas E Boyd, MD^4*, Robert N Raju, MD^5*, David N Barrera, DO⁶, Ernest Cochran, MD^7*, Philip Dien, MD^8*, David Hakimian, MD⁹, Roger M. Lyons, MD¹⁰, Peter J Schlegel, MD^11*, Svetislava J Vukelja, MD^12*, Julie Boston, RN^13*, Kristi A Boehm, MS^13*, Yunfei Wang, MS^13* and Lina Asmar, PhD^13*

¹Research, US Oncology Research, Inc., Houston, TX and Rocky Mountain Cancer Centers, Aurora, CO
²Research, US Oncology Research, Inc., Houston, TX and Hematology and Oncology Physicians, Tucson, AZ
³Research, US Oncology Research, Inc., Houston, TX and Northwest Cancer Specialists, Vancouver, WA
⁴Research, US Oncology Research, Inc., Houston, TX and Yakima Valley Memorial Hospital, Yakima, WA
⁵Research, US Oncology Research, Inc., Houston, TX and Dayton Oncology and Hematology, Kettering, OH
⁶Research, US Oncology Research, Inc., Houston, TX and Texas Oncology, Fort Worth, TX
⁷Research, US Oncology Research, Inc., Houston, TX and Texas Oncology, Paris, TX
⁸Research, US Oncology Research, Inc., Houston, TX and Minnesota Onc. Hem., Burnsville, MN
⁹Research, US Oncology Research, Inc., Houston, TX and Cancer Care and Hematology Associates, Niles, IL
¹⁰Research, US Oncology Research, Inc., Houston, TX Cancer Care Centers of South Texas, San Antonio, TX
¹¹Research, US Oncology Research, Inc., Houston, TX and Cancer Care Northwest, Spokane, WA
¹²Research, US Oncology Research, Inc., Houston, TX and Texas Oncology, Tyler, TX
¹³Research, US Oncology Research, Inc., Houston, TX

Steven Grant, MD¹, Daniel Sullivan^2*, David Roodman, MD, PhD³, Robert K Stuart, MD⁴, Edward Perkins^1*, Sarah Kolla^1*, Viswanathan Ramakrishnan^1*, John Wright, MD, PhD^5*, Alexander Dimitri Colevas^6*, M B Tombes^1* and John D Roberts^1*

¹Massey Cancer Center, Virginia Commonwealth University, Richmond, VA
²H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
³Medicine/Hem-Onc., University of Pittsburgh, Pittsburgh, PA
⁴Medical Univ. of South Carolina, Charleston, SC
⁵IDB CTEP NCI, Rockville, MD
⁶School of Medicine, Stanford University, Stanford, CA

Peter R Moosmann, MD, PhD^*, Marc Heizmann, MD, Nina Kotrubczik, MD^*, Mario Bargetzi, MD and Martin Wernli, MD

Center of Oncology, Hematology, & Transfusion Medicine, Cantonal Hospital of Aarau, Aarau, Switzerland

Remy Gressin, MD¹, Sylvie caulet Maugendre, MD^2*, Steven Le Gouill, MD^3*, Mario ojeda Uribe, MD^4*, Magda Alexis Vigier, MD^5*, Krimo Bouabdallah^6*, Christiane Mounier^7*, Olivier Tournilhac, MD^8*, Philippe Rodon, MD⁹, Abderrazak El Yamani^10*, Laurent Sutton^11*, Delphine Senecal, MD^12*, Bruno Lioure, MD^13*, David Assouline, MD^14*, Annie Le Mevel, MD^15*, Bruno Villemagne, MD^16*, Charles Dauriac, MD^17*, Martine Gardembas, MD^18*, Sophie Park, MD^19* and Thierry Lamy, PhD^17*

¹Dept. of Onc.-Haem., CHU Michallon, Grenoble, France
²Pathology, CHU Rennes, Rennes, France
³Haematology, CHU Nantes, Nantes, France
⁴Haematology, CH, Mulhouse, France
⁵Oncology, CH Orleans, Orleans, France
⁶Haematology, CHU Bordeaux, Pessac, France
⁷Haematology, CHU Saint Etienne, St Priest en Jarez, France
⁸Haematology, CHU Clermont Ferrand, Clermont Ferrand, France
⁹Haematology, CH Blois, Blois, France
¹⁰Haematology, CH Le Mans, Le Mans, France
¹¹CH Argenteuil, Argenteuil, France
¹²Haematology, CHU Tours, Tours, France
¹³Département d'Hématologie et d'Oncologie, CHU Hautepierre, Strasbourg, France
¹⁴Oncology, Clinique du Mail, Grenoble, France
¹⁵Haematology, Centre Anticancereux, Saint Herblain, France
¹⁶Haematology, CH La Roche sur Yon, La Roche sur Yon, France
¹⁷Haematology, CHU Rennes, Rennes, France
¹⁸Haematology, CHU Angers, Angers, France
¹⁹Haematology, CH Cochin, Paris, France

Laurie H Sehn, MD, MPH^1*, David A Macdonald, MD², Sheldon H. Rubin, MD³, Morel Rubinger, MD, FRCPC⁴, Kevin R Imrie, MD⁵, Judy-Anne W Chapman, PhD^6*, Marina Djurfeldt^7*, Lois Shepherd, MD⁶, Stephen Couban, MD⁸ and Michael Crump, MD⁹

¹British Columbia Cancer Agency, Vancouver, BC, Canada
²QEII Health Sciences Centre, Halifax, NS, Canada
³The Moncton Hospital, Moncton, NB, Canada
⁴Cancercare Manitoba, Winnipeg, MB, Canada
⁵Sunnybrook Hospital, Toronto, ON, Canada
⁶Queen's University, Kingston, ON, Canada
⁷National Cancer Institute of Canada Clinical Trials Group, Kingston, ON, Canada
⁸Sciences Centre, Queen Elizabeth II Health, Halifax, NS, Canada
⁹Princess Margaret Hospital, Toronto, ON, Canada